Foveal cone loss in tamoxifen maculopathy: a case report
Abstract
Tamoxifen is used in low dose concentrations (20–40 mg per day) as a therapy for breast cancer but is known to have ocular side effects. In this case report, the foveal cone integrity in a tamoxifen-treated patient who complained of a small central scotoma in the left eye while reading was examined using high resolution adaptive optics imaging.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 08, 2023
- Source ID
- 10.1186/s13256-023-04199-z
Entities
People
- Elaine M. Wells-gray
- Michael Wells
- Nathan Doble
- Stacey S. Choi
Organizations
- National Eye Institute
- United States Department of Defense